Success Story: Chemical Biology Expert Secures I-140 NIW Approval for Research Advancing Infectious Disease and Immunotherapy Strategies
Client’s Testimonial:
"Many thanks to B. and the Wegreen team. The case preparation process was highly organized and streamlined. I truly enjoyed working with them and appreciate their support in securing my NIW approval.”
On May 6th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Chemical Biology (Approval Notice).
General Field: Chemical Biology
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: May 6th, 2026
Processing Time: 10 months, 11 days (Premium Processing Upgrade Requested)
Case Summary:
We are pleased to share that the client, who holds a Ph.D. in chemistry and chemical biology, received approval for an I-140 NIW petition. The client is an expert in chemical biology and is currently conducting research in this field in the United States.
The client’s proposed endeavor focused on designing and applying advanced chemical biology, biochemical, and computational strategies to study bacterial communication, viral pathogenesis, and molecular mechanisms of immune presentation. This work was presented as nationally important because it combats antibiotic resistance, improves infectious disease outcomes, enhances cancer immunotherapeutic strategies, and supports rapid-response drug development for future public health emergencies.
In the petition, we demonstrated the client’s significance by connecting the research record to practical national needs in public health, infectious disease response, drug resistance, and biomedical innovation. Rather than presenting the client’s publication and citation metrics as automatically sufficient, we explained how an adjudicator could interpret them as evidence of independent reliance by other researchers and meaningful progress in a nationally important field.
The client’s record included 2 peer-reviewed journal articles, including 1 first-authored article, 6 first-authored abstracts, 1 preprint, and 5,000 citations. The petition also emphasized that one publication ranked among the top 0.01% most-cited articles in its field and year, showing that the client’s work had been relied upon at a level far beyond ordinary scholarly attention. While the provided materials did not list a separate peer-review service count, the evidence showed that the client’s published research had been reviewed, disseminated, and repeatedly used by others in chemical biology and related biomedical fields.
This approval recognizes the strength of a petition built around national importance, a focused proposed endeavor, and objective evidence of influence in the client’s field. We congratulate our client on this I-140 NIW approval and wish them continued success in advancing research with important public health applications in the United States.